Janux Therapeutics, Inc. (Nasdaq: JANX) ("Janux"), a clinical-stage biopharmaceutical company developing a broad pipeline of ...
Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...
Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...
In today's ACT Brief, we examine Veristat's acquisition of Certara's regulatory business, why reimbursement probability ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading SaaS provider of supplier orchestration solutions for the life sciences industry, today announced the launch of its Clinical ...
Advancements in Asthma Treatment: Next Steps and Insights From Clinical Development of Rilzabrutinib
Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies ...
Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...
Pharmaceutical Technology on MSN
The slow march of clinical biomarkers to become surrogate endpoints
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
India is expanding to 1,000 accredited clinical trial sites, signaling its ambition to become a global hub for drug ...
Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results